CLINICAL_TRIALS
trial_result
· 2018-04-27
Clinical Trial Update: Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects [Phase 3]
Summary
Phase 3 results for the GSK investigational compound GSK2585823 (STF115287) in acne vulgaris in Japanese subjects have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2018-04-27